Endothelial dysfunction induced by antibodies against angiotensin AT1 receptor in immunized rats
- PMID: 20835263
- PMCID: PMC4012898
- DOI: 10.1038/aps.2010.144
Endothelial dysfunction induced by antibodies against angiotensin AT1 receptor in immunized rats
Abstract
Aim: To investigate the association between autoantibodies against angiotensin AT1 receptor (AT1-AAs) and endothelial dysfunction in vivo.
Methods: Rat models with AT1 receptor antibodies (AT1-Abs) were established by active immunization for nine months. Lactate dehydrogenase (LDH) activity was regarded as an indicator of cell necrotic death. Endothelin-1 (ET-1) in the sera of rats was determined and endothelium-dependent vasodilatation was detected in isolated thoracic aorta. Endothelial intercellular adhesion molecule-1 (ICAM-1) expression in aorta endothelium was assessed using confocal microscopy. Coronary artery endothelial ultrastructure was observed.
Results: IgGs in the immunized group significantly increased the LDH activity (0.84±0.17 vs 0.39±0.12, P<0.01 vs vehicle group IgGs)in incubated human umbilical vein endothelial cells through AT1 receptor. Higher content of ET-1 occurred in the immunized rats than that of the vehicle group, and reached two peaks at month 3 (27±4 ng/L, P<0.01) and month 7 (35±5 ng/L, P<0.01), respectively. In addition, aortic endothelium-dependent vasodilatation was attenuated; endothelial ICAM-1 level was markedly increased and cardiac capillary endothelium was damaged following immunization.
Conclusion: Our study demonstrated that AT1-Abs contributed to endothelial dysfunction in vivo, which was a potential mechanism through which the antibodies play vital roles in related diseases.
Figures






Similar articles
-
Autoantibodies isolated from preeclamptic patients induce endothelial dysfunction via interaction with the angiotensin II AT1 receptor.Cardiovasc Toxicol. 2014 Mar;14(1):21-9. doi: 10.1007/s12012-013-9229-8. Cardiovasc Toxicol. 2014. PMID: 24122090
-
Antibodies against AT1 receptors are associated with vascular endothelial and smooth muscle function impairment: protective effects of hydroxysafflor yellow A.PLoS One. 2013 Jun 24;8(6):e67020. doi: 10.1371/journal.pone.0067020. Print 2013. PLoS One. 2013. PMID: 23826187 Free PMC article.
-
The role of NO-cGMP pathway inhibition in vascular endothelial-dependent smooth muscle relaxation disorder of AT1-AA positive rats: protective effects of adiponectin.Nitric Oxide. 2019 Jun 1;87:10-22. doi: 10.1016/j.niox.2019.02.006. Epub 2019 Mar 1. Nitric Oxide. 2019. PMID: 30831264
-
The Role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia.Curr Pharm Biotechnol. 2018;19(10):781-785. doi: 10.2174/1389201019666180925121254. Curr Pharm Biotechnol. 2018. PMID: 30255752 Free PMC article. Review.
-
Endothelium-derived vasoactive agents, AT1 receptors and inflammation.Pharmacol Ther. 2011 Aug;131(2):187-203. doi: 10.1016/j.pharmthera.2010.11.001. Epub 2010 Nov 27. Pharmacol Ther. 2011. PMID: 21115037 Review.
Cited by
-
Effect of photobiomodulation on endothelial cell exposed to Bothrops jararaca venom.Lasers Med Sci. 2016 Jul;31(5):1017-25. doi: 10.1007/s10103-016-1941-8. Epub 2016 May 4. Lasers Med Sci. 2016. PMID: 27147074
-
Receptor-activating autoantibodies and disease: preeclampsia and beyond.Expert Rev Clin Immunol. 2011 Sep;7(5):659-74. doi: 10.1586/eci.11.56. Expert Rev Clin Immunol. 2011. PMID: 21895478 Free PMC article. Review.
-
Frontiers of vascular biology and disease research.Acta Pharmacol Sin. 2010 Oct;31(10):1241-2. doi: 10.1038/aps.2010.179. Acta Pharmacol Sin. 2010. PMID: 20921953 Free PMC article. No abstract available.
-
Autoantibodies against AT1 Receptor Contribute to Vascular Aging and Endothelial Cell Senescence.Aging Dis. 2019 Oct 1;10(5):1012-1025. doi: 10.14336/AD.2018.0919. eCollection 2019 Oct. Aging Dis. 2019. PMID: 31595199 Free PMC article.
-
Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson's disease models.Stem Cell Res Ther. 2024 May 12;15(1):138. doi: 10.1186/s13287-024-03751-y. Stem Cell Res Ther. 2024. PMID: 38735991 Free PMC article.
References
-
- Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000;52:11–34. - PubMed
-
- Roberts JM. Angiotensin-1 receptor autoantibodies: a role in the pathogenesis of preeclampsia. Circulation. 2000;101:2335–7. - PubMed
-
- Fleming S. Malignant hypertension - the role of the paracrine renin-angiotensin system. J Pathol. 2000;192:135–9. - PubMed
-
- Nakashima H, Suzuki H, Ohtsu H, Chao JY, Utsunomiya H, Frank GD, et al. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol. 2006;4:67–78. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous